Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Topic's Include: Covid Queries: Altered DNA and microchips, Mayo Clinic Minute: Flu during a pandemic, and COVID-19 media only news briefing: Kids, COVID-19 and fall festivities / tips for staying safe.
Today's Highlight's Include: Walz to announce plans Friday morning to address hospital capacity, expanding COVID rapid testing, hospitals brace for an onslaught this winter, from flu as well as COVID, and Mayo announces urgent need for O+ and O- blood types.
It can be hard to know when to use a rapid at-home COVID-19 test and how to interpret the results. Dr. Binnicker reviews the pros and cons of these tests, and explains when you need to get tested by a lab.
In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity and 100% specificity. This is the first assay of its kind that can detect viral antigens “directly from clinical specimens” such as nasopharyngeal swabs. Mass spectrometry is a sensitive technique used to detect, identify, and quantitate molecules present in a sample.
This week’s research roundup features: Effect of urate-elevating inosine on early Parkinson disease progression: The SURE-PD3 randomized clinical trial.
Topic's Include: COVID-19 media only news briefing: What we know so far about post-COVID syndrome, Mayo Clinic Q&A podcast: The case for continuing COVID-19 precautions, and COVID queries: The speed of vaccine development.
Topic's Include: Breast Cancer Awareness: What experts want you to know about prevention, 50 Years of CT: then, now, and what’s to come, and Pfizer asks FDA to authorize covid-19 vaccine in young children.
In this episode of “Lab Medicine Rounds,” Ann Moyer, M.D., Ph.D., guest hosts Justin Kreuter, M.D., chair of the Mayo Clinic Alix School of Medicine Social Media Committee and a faculty lecturer for Harvard Macy Institute on professional use of social media, to discuss the challenges and opportunities of being a professional on social media.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice talks about his participation in President Biden’s Global COVID-19 Summit and discusses the toll the pandemic has taken on countries around the world.
In October 2021, Mayo Clinic Laboratories announced eleven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
As a referral specialist who works at a client site, Alonda Snelling-Faulk enjoys being part of the connection between patients and their test results. And as part of her job, she’s eager to learn all she can about the tests and what they mean for the people Mayo Clinic Laboratories serves.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).